Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.48 |
| ▸ | PRKDC | P78527 | 1/20 | 0.41 |
| ▸ | CSF1R | P07333 | 1/20 | 0.41 |
| ▸ | LPL | P06858 | 5/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22135386 | 0.95 | ALOX5 (0.50) | ALOX5PRKDCCSF1RLPLLIPG | |
| SCHEMBL22737993 | 0.95 | ALOX5 (0.50) | ALOX5PRKDCCSF1RLPLLIPG | |
| SCHEMBL22760814 | 0.95 | ALOX5 (0.50) | ALOX5PRKDCCSF1RLPLLIPG | |
| SCHEMBL21756048 | 0.92 | ALOX5 (0.45) | ALOX5PRKDCCSF1RLPLLIPG | |
| SCHEMBL24264016 | 0.90 | LIPG (0.42) | ALOX5CSF1RLPLLIPGHSP90AA1 | |
| SCHEMBL22738106 | 0.90 | ALOX5 (0.47) | ALOX5PRKDCCSF1RLPLLIPG | |
| SCHEMBL24264177 | 0.88 | LIPG (0.49) | CSF1RLPLLIPGHSP90AA1HSP90AB1 | |
| SCHEMBL25073616 | 0.87 | LIPG (0.54) | ALOX5PRKDCCSF1RLPLLIPG | |
| SCHEMBL20259765 | 0.87 | LIPG (0.49) | ALOX5PRKDCCSF1RLPLLIPG | |
| SCHEMBL24264228 | 0.87 | LIPG (0.48) | CSF1RLPLLIPGHSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11832517-B2 | Heterocyclic compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-11-28 | — | — | US | disclosed |
| US-11832517-B2 | Heterocyclic compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-11-28 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20220059778-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-02-24 | — | — | US | disclosed |
| WO-2022015084-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2022-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220059778-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, TRPC1, CYP1A1 | ALOX5 1152/4885PRKDC 4335/4885CSF1R 1612/4885 |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CYP1A2, CYP1A1 | ALOX5 1552/4885PRKDC 3767/4885CSF1R 3129/4885 |
| US-11832517-B2 | Heterocyclic compound and organic light emitting device comprising same | CRY1, TRPC1, CYP1A1 | ALOX5 1152/4885PRKDC 4335/4885CSF1R 1612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.